
Pharmacally
Hunter Syndrome
Approvals, trial readouts, research and drug safety alerts, interpreted by pharmacists and checked against the primary source.
Latest in Hunter Syndrome
Mergers & AcquisitionsItalfarmaco, JCR Sign JR-141 Licensing Deal for Hunter SyndromeItalfarmaco and JCR Pharmaceuticals have signed an exclusive licensing agreement for JR-141 (pabinafusp alfa), an investigational blood-brain barrier-penetrating enzyme replacement therapy being evaluated for Hunter syndrome in a…Fact-Checked
New Drug ApprovalGC Green Cross Secures Hunterase Approvals for Hunter Syndrome in India and TaiwanGC Green Cross has secured approval for Hunterase IV in India and Taiwan and Hunterase ICV in Taiwan, expanding access to systemic and CNS-directed treatment options for Hunter…Fact-Checked
Clinical TrialsFDA Places Clinical Hold on REGENXBIO’s RGX-121 After Spine MRI Findings in Hunter Syndrome StudyREGENXBIO’s investigational gene therapy RGX-121 has been placed on FDA clinical hold after asymptomatic spine MRI findings were identified in five participants with Hunter syndrome.Fact-Checked
Explore more
Health TidingsIndustry, pipeline and company news.
RegulatoryApprovals, policy and agency decisions.
ResearchPeer-reviewed studies and scientific breakthroughs.
Drug FinderLook up any drug: uses, dosing and safety.
From the HistoryLandmark moments in pharmaceutical history.
LatestEvery new story, as soon as it is published.